Dr.Max made a net profit of CZK 762 mil with revenues of CZK 24,796 mil in 2022, up by 31.7% and up by 9.88%, respectively, compared to the previous year.
This translates into a net margin of 3.07%. Historically, between 2013 and 2022, the firm’s net margin reached a high of 6.72% in 2014 and a low of -1.32% in 2015. The average net margin in the last five years amounted to 2.22%.
On the operating level, the EBITDA margin reached 6.86% and EBIT amounted to 5.01% of sales in 2022.
You can see all the company’s data at Dr.Max profile, or you can download a report on the company in the report section.
Helgi Library 
